These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1486148)

  • 21. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia.
    Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hassett A; Matheson B; Hill C; Mackie B; Singh B; Hirt J
    Psychiatry Res; 1993 Jul; 48(1):79-90. PubMed ID: 8416019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE; Blake IM
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
    Johnson GF; Hunt GE
    Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Antonozzi I; Frajese G
    Neuropsychobiology; 1990; 23(1):15-7. PubMed ID: 2280826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
    Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
    Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
    Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.
    Whalley LJ; Christie JE; Brown S; Arbuthnott GW
    Arch Gen Psychiatry; 1984 Nov; 41(11):1040-3. PubMed ID: 6497565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia.
    Lin CH; Kuo CC; Chou LS; Chen YH; Chen CC; Huang KH; Lane HY
    J Clin Psychopharmacol; 2010 Oct; 30(5):518-25. PubMed ID: 20814315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
    Davis BM; Davis KL; Mohs RC; Mathé AA; Rothpearl AB; Johns CA; Levy MI; Horvath TB
    Arch Gen Psychiatry; 1985 Mar; 42(3):259-64. PubMed ID: 3977547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma haloperidol levels: clinical response and fancy mathematics.
    Van Putten T; Marder SR; Mintz J
    Arch Gen Psychiatry; 1985 Aug; 42(8):835-8. PubMed ID: 4015328
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S
    Psychopharmacology (Berl); 2002 Jun; 162(1):63-6. PubMed ID: 12107619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of very poor outcome schizophrenia.
    Keefe RS; Mohs RC; Losonczy MF; Davidson M; Silverman JM; Kendler KS; Horvath TB; Nora R; Davis KL
    Am J Psychiatry; 1987 Jul; 144(7):889-95. PubMed ID: 3605400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients.
    Otani K; Kondo T; Kaneko S; Ishida M; Fukushima Y
    Int Clin Psychopharmacol; 1994; 9(4):287-9. PubMed ID: 7868851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
    Liu KL; Lung FW
    Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schneiderian versus Bleulerian schizophrenia and basic symptoms.
    Peralta V; Cuesta MJ
    Psychopathology; 1991; 24(3):151-7. PubMed ID: 1754645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.